Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Prediction Markets
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
  • WIIM
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Initiation

Initiation

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Initiation

Why Regeneron Pharmaceuticals Analyst Says Competitive Concerns Are Overblown, Pipeline Opportunity Underappreciated

By Shanthi Rexaline
Today, 10:44 PM
Regeneron Pharmaceuticals Inc.'s (NASDAQ: REGN) robust pipeline and attractive valuation has prompted an analyst at HC Wainwright to join the bullish camp.

NTLA

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Litchfield Hills Initiates Coverage On Adial Pharmaceuticals with Buy Rating, Announces Price Target of $5

By Benzinga Newsdesk
Today, 10:44 PM
Litchfield Hills initiates coverage on Adial Pharmaceuticals (NASDAQ:ADIL) with a Buy rating and announces Price Target of $5.

ADIL

Read More
7 minute read
  • Analyst Ratings
  • Downgrades
  • Initiation
  • Intraday Update
  • Upgrades

Benzinga’s Top Ratings Upgrades, Downgrades For June 29, 2021

By Benzinga Insights
Today, 10:44 PM
 

AR

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Aegis Capital Initiates Coverage On XOMA with Buy Rating, Announces Price Target of $60

By Benzinga Newsdesk
Today, 10:44 PM
Aegis Capital analyst Nathan Weinstein initiates coverage on XOMA (NASDAQ:XOMA) with a Buy rating and announces Price Target of $60.

XOMA

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Northland Capital Markets Initiates Coverage On NewHold Investment with Outperform Rating, Announces Price Target of $16

By Benzinga Newsdesk
Today, 10:44 PM
Northland Capital Markets analyst Michael Latimore initiates coverage on NewHold Investment (NASDAQ:NHIC) with a Outperform rating and announces Price Target of $16.

NHIC

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Noble Capital Markets Initiates Coverage On Digerati Technologies with Outperform Rating, Announces Price Target of $0.23

By Benzinga Newsdesk
Today, 10:44 PM
Noble Capital Markets analyst Michael Kupinski initiates coverage on Digerati Technologies (OTC:DTGI) with a Outperform rating and announces Price Target of $0.23.

DTGI

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News

William Blair Initiates Coverage On Zymergen with Outperform Rating

By Benzinga Newsdesk
Today, 10:44 PM
William Blair analyst Matt Larew initiates coverage on Zymergen (NASDAQ:ZY) with a Outperform rating.

ZY

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Piper Sandler Initiates Coverage On Oasis Petroleum with Overweight Rating, Announces Price Target of $115

By Benzinga Newsdesk
Today, 10:44 PM
Piper Sandler analyst Kashy Harrison initiates coverage on Oasis Petroleum (NASDAQ:OAS) with a Overweight rating and announces Price Target of $115.

OAS

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Cantor Fitzgerald Initiates Coverage On Magenta Therapeutics with Overweight Rating, Announces Price Target of $20

By Benzinga Newsdesk
Today, 10:44 PM
Cantor Fitzgerald analyst Emma Nealon initiates coverage on Magenta Therapeutics (NASDAQ:MGTA) with a Overweight rating and announces Price Target of $20.

MGTA

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Barclays Initiates Coverage On Marathon Petroleum with Overweight Rating, Announces Price Target of $71

By Benzinga Newsdesk
Today, 10:44 PM
Barclays analyst Theresa Chen initiates coverage on Marathon Petroleum (NYSE:MPC) with a Overweight rating and announces Price Target of $71.

MPC

Posts navigation

Previous 1 … 697 698 699 … 742 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service